Description
Geldanamycin is an inhibitor of heat shock protein 90 (HSP90) that exhibits antiviral, neuroprotective, and anticancer activities. Geldanamycin decreases viral titers and inflammation in animal models of Chikungunya virus infection. Geldanamycin also accelerates nerve regeneration and enhances functional recovery in animal models of nerve crush injury. Additionally, geldanamycin sensitizes various cancer cell lines to the effects of other co-administered chemotherapeutics.